Applied DNA Sciences (APDN)
(Delayed Data from NSDQ)
$0.41 USD
-0.01 (-3.51%)
Updated Jul 26, 2024 04:00 PM ET
After-Market: $0.41 0.00 (-0.02%) 7:58 PM ET
2-Buy of 5 2
C Value B Growth C Momentum B VGM
Price, Consensus and EPS Surprise
APDN 0.41 -0.01(-3.51%)
Will APDN be a Portfolio Killer in July?
Zacks Investment Research is releasing its prediction for APDN based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for APDN
Applied DNA Sciences (APDN) Upgraded to Buy: What Does It Mean for the Stock?
Why You Should Bet on 5 Top-Ranked Stocks With Rising P/E
APDN: What are Zacks experts saying now?
Zacks Private Portfolio Services
Time to Play 5 Top-Ranked Stocks With Rising P/E?
Applied DNA Sciences (APDN) Reports Q2 Loss, Tops Revenue Estimates
Clear Secure (YOU) Q1 Earnings and Revenues Top Estimates
Other News for APDN
Applied DNA Enters into Multi-Year Commercialization Agreement with Indus Group for Large-Scale Implementation of CertainT Cotton Traceability
Applied DNA enters multiyear commercialization agreement with Indus Group
Applied DNA Sciences signs five-year license agreement with Indus
Applied DNA Sciences announces U.S. DLA exercises one-year option period
U.S. Defense Logistics Agency Exercises 1-Year Option Period in Applied DNA Counterfeit Mitigation Contract